cagrilintide retatrutide blend GLP-3 Research Peptide | Triple Incretin Amylin Cagrilintide 10mg Research Peptide |

, & Mu, D

With a plasma half-life of approximately 160 hours achieved through precise molecular engineering semaglutide stands apart from earlier GLP-1 analogs as a uniquely powerful and pharmacokinetically stable compound for laboratory investigation

Patent 6,335,319

Sample 16-week strength protocol Weeks 1-16 (base): CJC-1295: 200mcg nightly Ipamorelin: 200mcg nightly BPC-157: 250mcg twice daily Weeks 1-6 (IGF-1 cycle): Add IGF-1 LR3: 60mcg post-workout Weeks 7-12 (off IGF-1): Continue base protocol only Weeks 13-16 (optional second IGF-1 cycle): Add IGF-1 LR3: 60mcg post-workout Expected outcome: 15-20 lbs muscle gain 25-40% strength increase in major lifts Minimal injuries Excellent body composition Use our peptide cycle planning guide for detailed cycle planning, peptide dosage chart for reference doses, and how to calculate peptide dosages for precision